Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Amedisys, Inc. (AMED) had Consolidated Net Income/Loss of $14.59M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$571.41M |
|
$14.40M |
|
$321.54M |
|
$249.88M |
|
$539.79M |
|
$31.62M |
|
$-4.39M |
|
$27.23M |
|
$27.23M |
|
$14.59M |
|
$14.59M |
|
|
Consolidated Net Income/Loss |
$14.59M |
$14.59M |
|
$31.62M |
|
$46.57M |
|
32.67M |
|
32.98M |
|
$0.44 |
|
$0.44 |
|
| Balance Sheet Financials | |
$526.45M |
|
$42.68M |
|
$1.56B |
|
$2.09B |
|
$484.86M |
|
$356.08M |
|
$462.36M |
|
$947.22M |
|
$1.14B |
|
$-203.80M |
|
$1.14B |
|
32.68M |
|
| Cash Flow Statement Financials | |
$-6.54M |
|
$-3.07M |
|
$-8.55M |
|
$138.86M |
|
$120.70M |
|
$-18.16M |
|
$7.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.09 |
|
-- |
|
-- |
|
0.24 |
|
0.34 |
|
43.73% |
|
5.53% |
|
5.53% |
|
-- |
|
4.76% |
|
2.52% |
|
$-9.19M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
-- |
|
1.59 |
|
56.60 |
|
1.28% |
|
-7.16% |
|
0.70% |
|
0.97% |
|
$34.97 |
|
$-0.28 |
|
$-0.20 |
|